+31 31 0
Published 9 years ago by tukka with 1 Comments
by tukka
9 years ago 1

$750/pill pharma company under investigation by Senate for price gouging

Martin Shkreli, CEO of Turing Pharmaceuticals, just got a letter from the US Senate. And it’s not a nice letter. It was sent by US Senators Susan Collins and Claire McCaskill, leaders of the Senate Special Committee on Aging, who are concerned by recent drug pricing practices. In addition to Shkreli, the senators sent letters to the heads of three other pharmaceutical companies, namely Valeant Pharmaceuticals, Retrophin, Inc., and Rodelis Therapeutics.

Continue Reading http://arstechnica.com

Join the Discussion

  • Auto Tier
  • All
  • 1
  • 2
  • 3
Post Comment
  • Gozzin
    +4

    Good. I so want to beat that smug expression off his sanctimonious, face.

    9 years ago
    Reply
    Save

Here are some other snaps you may like...

discover your
interests.

Check out our front page for a lot more stuff!

Martin Shkreli Invokes Fifth in Refusing to Give Records to Lawmakers

$750 Daraprim pill now has a $1 generic alternative | Toronto Star

Senate committee talks Turing—“My biggest challenge is to not lose my temper”

Of Rotten Apples and Rotten Systems

Drug CEO Will Lower Price of Daraprim After Hike Sparked Outrage